i2o Therapeutics
PrivateLast Round
Series A
Aug 28, 2023
Total Funding Raised
$50M
Company Overview
i2O Therapeutics is a biotechnology company that develops innovative ionic liquid technology aimed at treating metabolic and inflammatory diseases by enhancing the delivery and efficacy of peptides, proteins, and other injectable medications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
i2o Therapeutics Comps
Public and private peers based on sector, stage, and business model.
i2o Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 28, 2023 | ||||
| VC Round | Dec 3, 2020 | ||||
| Seed | Apr 9, 2020 |
i2o Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cerity Partners Ventures | Series A |
| HM Venture Partners | Series A |
| Colorcon Ventures | Series A, VC Round |
| Sanofi Ventures | Seed |
| 7G Bioventures | Series A |
| Hikma Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors grew 143% MoM, reaching 657.
i2o Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about i2o Therapeutics's valuation, stock price, and market status.
